Literature DB >> 6309647

Genetic control of adrenergic receptors on human platelets. A twin study.

P Propping, W Friedl.   

Abstract

It was examined whether genetic factors are involved in the expression of alpha-2 adrenergic receptors on human platelets, as measured with 3H-yohimbine as ligand. The twin series comprised 17 monozygotic and 15 dizygotic adult, healthy, male, drug-free twin pairs. For control of intraindividual and interassay variation, 13 unrelated pairs of subjects were examined. Bmax values for 3H-yohimbine binding (range 91-305 fmol/mg protein) proved to be under considerable genetic control; this was not the case for KD values. Different possible genetic mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309647     DOI: 10.1007/bf00327103

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  14 in total

1.  Familial hypercholesterolemia: A genetic defect in the low-density lipoprotein receptor.

Authors:  M S Brown; J L Goldstein
Journal:  N Engl J Med       Date:  1976-06-17       Impact factor: 91.245

2.  Synthetic alpha-adrenergic agonists are potent alpha-adrenergic blockers in human platelets.

Authors:  K H Jakobs
Journal:  Nature       Date:  1978-08-24       Impact factor: 49.962

Review 3.  Signal transformation mediated by membrane receptors for hormones and neurotransmitters.

Authors:  G Schultz; K Aktories; E Böhme; R Gerzer; K H Jakobs
Journal:  Mol Immunol       Date:  1982-10       Impact factor: 4.407

4.  Genetic control of ethanol action on the central nervous system. An EEG study in twins.

Authors:  P Propping
Journal:  Hum Genet       Date:  1977-03-14       Impact factor: 4.132

5.  Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine.

Authors:  H J Motulsky; S J Shattil; P A Insel
Journal:  Biochem Biophys Res Commun       Date:  1980-12-31       Impact factor: 3.575

6.  Age-dependent decrease of alpha 2-adrenergic receptor number in human platelets.

Authors:  O E Brodde; M Anlauf; N Graben; K D Bock
Journal:  Eur J Pharmacol       Date:  1982-07-09       Impact factor: 4.432

7.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

8.  Genetics of the low density lipoprotein receptor: III. Evidence for multiple normal alleles at the low density lipoprotein receptor locus.

Authors:  K Maartmann-Moe; P Magnus; W Golden; K Berg
Journal:  Clin Genet       Date:  1981-08       Impact factor: 4.438

9.  Genetics of the low density lipoprotein receptor: II. Genetic control of variation in cell membrane low density lipoprotein receptor activity in cultured fibroblasts.

Authors:  P Magnus; K Maartmann-Moe; W Golden; W E Nance; K Berg
Journal:  Clin Genet       Date:  1981-08       Impact factor: 4.438

10.  Pathogenetic mechanisms of hereditary diabetes mellitus.

Authors:  H W Rüdiger; M Dreyer
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

View more
  4 in total

Review 1.  Heredity and the autonomic nervous system in human hypertension.

Authors:  D T O'Connor; P A Insel; M G Ziegler; V Y Hook; D W Smith; B A Hamilton; P W Taylor; R J Parmer
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

2.  Study of V1a vasopressin receptor gene single nucleotide polymorphisms in platelet vasopressin responsiveness.

Authors:  Kazi N Hasan; Masaru Shoji; Shoji Tsutaya; Ryoko Kudo; Eriko Matsuda; Junko Saito; Tokihisa Kimura; Minoru Yasujima
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

Review 3.  Research strategies in human behaviour genetics.

Authors:  F Vogel
Journal:  J Med Genet       Date:  1987-03       Impact factor: 6.318

Review 4.  [Twin research in Germany].

Authors:  Paul Enck; Miriam Goebel-Stengel; Olaf Rieß; Jeannette Hübener-Schmid; Karl Oliver Kagan; Andreas Michael Nieß; Henning Tümmers; Urban Wiesing; Stephan Zipfel; Andreas Stengel
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-09-15       Impact factor: 1.513

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.